Olá LATAM

ANVISA Approves Merck's Winrevair for PAH in Brazil | ANVISA Drug Approvals | Aprovações de medicamentos da ANVISA | iPharmaCenter

Winrevair (sotatercept) has been approved for treating adults with pulmonary arterial hypertension (PAH), classified under World Health...

16, April 2024 Rybrevant is approved in Brazil for locally advanced or metastatic non-small cell lung cancer Rybrevant (amivantamab) is...

Brazilian Health Ministry Decided to Use Unspent R$17 billion ($3.4 billion) Which was Not utilized During COVID-19 Period Approximately...

Sign me up!